Wang et al. [39] found 23 (4.8%) of 475 AML patients to bear mutated IKZF1. In RNA sequencing, they delineated three clusters of IKFZ-mutated patients: N159S (40%), co-occurring CEBPA mutations (43%), and others (17%) [39]. Here, CEBPA is linked to acute myeloid leukemia.